Gossamer Bio
GOSS
GOSS
105 hedge funds and large institutions have $155M invested in Gossamer Bio in 2024 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.68% less ownership
Funds ownership: 77.3% → 75.62% (-1.7%)
10% less capital invested
Capital invested by funds: $173M → $155M (-$17.6M)
Holders
105
Holding in Top 10
1
Calls
$1.1M
Puts
$598K
Top Buyers
| 1 | +$8.29M | |
| 2 | +$2.75M | |
| 3 | +$1.38M | |
| 4 |
6CM
683 Capital Management
New York
|
+$1.06M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.05M |
Top Sellers
| 1 | -$7.3M | |
| 2 | -$5.8M | |
| 3 | -$3.02M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.56M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$880K |